| | | 54842 | | 10.02.1999 | | Sanofi-Aventis (Suisse) SA | | 19.12.2006 | | | | | | | | | | | 02.07.20. | | | | 02.07.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | CoAprovel 150/12.5 | comprimés filmés | Coated tablets (Irbesartan 150 mg, Hydrochlorothiazide 12.5 mg) | C09DA04 | CI | | 02 | CoAprovel 300/12.5 | comprimés filmés | Coated tablets (Irbesartan 300 mg, Hydrochlorothiazide 12.5 mg) | C09DA04 | CI | | 03 | CoAprovel 300/25 | comprimés filmés | Coated tablets (Irbesartan 300 mg, Hydrochlorothiazide 25 mg) | C09DA04 | CI |
|
|
